Conference Coverage

Nonmyeloablative conditioning gets a radiation boost for severe hemoglobinopathies

Publish date: March 13, 2018

 

REPORTING FROM THE 2018 BMT TANDEM MEETINGS

SOURCE: Bolaños-Meade J et al. BMT Tandem Meetings, Abstract LBA-3.

Pages

Recommended Reading

HCT-CI score may predict mortality for nonmalignant disease
MDedge Hematology and Oncology
Drug nets orphan designation for beta-thalassemia
MDedge Hematology and Oncology
HSCT approach provides ‘excellent’ survival in FA
MDedge Hematology and Oncology
CHMP endorses drug delivery system
MDedge Hematology and Oncology
Expanded UCB product can stand alone
MDedge Hematology and Oncology
Minihaplo-BMT can cure severe hemoglobinopathies
MDedge Hematology and Oncology
NK-cell therapy in resistant MDS, AML
MDedge Hematology and Oncology
Young kids with SCA not receiving recommended prophylaxis
MDedge Hematology and Oncology
Azacitidine now available in China
MDedge Hematology and Oncology
FDA expands approved use of ferumoxytol injection
MDedge Hematology and Oncology